Verified Service Provider in Mauritania
Dose Management Program in Mauritania
Engineering Excellence & Technical Support
Monitor and optimize patient radiation dose across modalities. High-standard technical execution following OEM protocols and local regulatory frameworks.
Optimized Prescription Protocols
Implemented standardized, evidence-based prescription protocols for common diseases, reducing variability and improving the appropriateness of medication selection and dosage. This initiative leverages data analytics from the Dose Management Program to identify trends and inform protocol updates, ensuring alignment with national health priorities and available resources.
Centralized Medication Database & Inventory
Established a robust, centralized medication database integrated with real-time inventory management across all participating health facilities. This system tracks drug availability, expiry dates, and consumption patterns, enabling proactive procurement, preventing stockouts of essential medicines, and minimizing waste due to expired medications, directly impacting the efficiency of the Dose Management Program.
Enhanced Healthcare Professional Training
Developed and delivered comprehensive training modules for healthcare professionals on rational drug use, dosage calculations, and the proper utilization of the Dose Management Program's digital tools. This capacity-building initiative aims to equip prescribers and pharmacists with the knowledge and skills to optimize patient outcomes and ensure safe and effective medication management within the Mauritanian healthcare system.
What Is Dose Management Program In Mauritania?
A Dose Management Program (DMP) in Mauritania refers to a structured, systematic approach to optimizing the use of medications, particularly high-cost, high-risk, or critically important pharmaceuticals. The primary objective is to ensure that patients receive the most appropriate and effective medication therapy, at the correct dose, for the optimal duration, and at the lowest possible cost, while minimizing adverse drug events (ADEs) and antimicrobial resistance (AMR). These programs are crucial for resource-limited settings like Mauritania, where drug procurement and access can be significant challenges.
| Who Needs Dose Management Programs | Typical Use Cases | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Patients requiring chronic medications: Particularly those with complex regimens or high out-of-pocket expenses, to ensure affordability and adherence. | Patients with chronic diseases (e.g., diabetes, hypertension, cardiovascular diseases): Optimizing drug selection and dosing for long-term management to improve outcomes and reduce complications. | Patients undergoing treatment for infectious diseases: Especially with complex or novel antimicrobial agents, to ensure appropriate use and prevent resistance. | Pediatric and Geriatric populations: These groups are often more vulnerable to ADEs and may require specialized dosing adjustments. | Patients with a history of adverse drug events: Requiring careful medication review and selection. | Patients in public health facilities: Where resource allocation and cost-effectiveness are paramount. | Patients prescribed high-cost medications: Including biologics, specialized oncology drugs, or novel therapies, to ensure appropriate indication and cost containment. | Healthcare Providers (Physicians, Pharmacists, Nurses): To support evidence-based prescribing, dispensing, and medication administration practices. | Healthcare Institutions (Hospitals, Clinics): To manage drug expenditures, improve patient safety, and optimize clinical outcomes. | National Health Authorities: To develop national drug policies, guide procurement strategies, and monitor drug utilization patterns across the country. |
| Antibiotic Stewardship Programs: Implementing guidelines for appropriate antibiotic prescribing to combat rising antimicrobial resistance. | Pain Management Programs: Optimizing opioid and non-opioid analgesic use to manage pain effectively while minimizing risks of addiction and overdose. | Cardiovascular Medication Management: Ensuring appropriate use of antihypertensives, statins, and antiplatelet agents for optimal cardiovascular health. | Diabetes Management: Rationalizing the use of oral hypoglycemic agents and insulin to achieve glycemic control and prevent complications. | Oncology Drug Management: Ensuring appropriate selection and dosing of chemotherapy and targeted therapies based on specific cancer types and patient profiles. | Management of Specialty Pharmaceuticals: Overseeing the use of high-cost drugs for conditions like rheumatoid arthritis, multiple sclerosis, or hepatitis C. | Medication Therapy Management (MTM) services: Provided to patients to optimize therapeutic outcomes through improved medication use, especially for those with multiple chronic conditions and multiple medications. | Post-discharge medication reconciliation: Ensuring continuity of care and preventing medication errors when patients transition from hospital to home. |
Key Components of a Dose Management Program in Mauritania
- Drug Utilization Review (DUR): Retrospective and prospective evaluation of medication prescribing and dispensing patterns to identify and correct potential medication-related problems.
- Therapeutic Interchange/Substitution: Implementing guidelines and protocols to allow pharmacists to substitute a prescribed medication with a therapeutically equivalent, often lower-cost, alternative, subject to prescriber approval or pre-defined protocols.
- Formulary Management: Developing and maintaining a list of essential and cost-effective medications approved for use within healthcare facilities, based on evidence-based guidelines and local needs.
- Antimicrobial Stewardship: A coordinated set of actions required to promote the optimal selection, dosage, route of administration, and duration of antimicrobial therapy, crucial for combating AMR.
- Cost-Effectiveness Analysis: Evaluating the economic impact of different drug choices and treatment regimens to identify the most efficient allocation of limited healthcare resources.
- Patient Education and Adherence Support: Implementing strategies to ensure patients understand their medication regimens, potential side effects, and the importance of compliance, thereby improving therapeutic outcomes.
- Data Collection and Monitoring: Establishing systems to track medication use, costs, ADEs, and outcomes to inform program evaluation and continuous improvement.
Who Needs Dose Management Program In Mauritania?
A dose management program is crucial for optimizing medication use and ensuring patient safety in Mauritania's healthcare system. Such programs aim to achieve the most effective and safe drug outcomes while minimizing costs. This requires a systematic approach involving various stakeholders and departments to ensure proper prescription, dispensing, administration, and monitoring of medications.
| Department/Customer | Role in Dose Management | Specific Needs/Focus | Potential Benefits of Program |
|---|---|---|---|
| Inpatient Wards (Medical, Surgical, Pediatric, etc.) | Direct patient care, prescription, and administration of medications. | Accurate dosing, avoiding medication errors, drug interactions, adherence. | Reduced length of stay, decreased adverse drug events, improved patient outcomes, cost savings on unnecessary medications. |
| Outpatient Clinics | Prescribing and advising patients on medication use for chronic and acute conditions. | Appropriate drug selection, patient education on adherence and side effects, rational prescribing. | Improved management of chronic diseases, reduced hospital readmissions, enhanced patient self-care. |
| Hospital Pharmacy | Procurement, storage, dispensing, compounding (if applicable), and medication reconciliation. | Inventory management, ensuring drug availability, checking prescriptions for appropriateness, providing drug information to prescribers and nurses. | Reduced drug stockouts, improved medication safety, efficient dispensing, cost-effective purchasing. |
| Community Pharmacies | Dispensing medications to outpatients, patient counseling, and over-the-counter (OTC) drug recommendations. | Ensuring correct medication is dispensed, patient education on proper usage and potential interactions, identifying potential drug-related problems. | Improved medication adherence in the community, reduced self-medication errors, early detection of drug issues. |
| Infection Control Department | Managing antibiotic use and preventing antimicrobial resistance. | Developing and implementing antibiotic stewardship guidelines, monitoring antibiotic usage patterns. | Reduced rates of healthcare-associated infections, optimized antibiotic effectiveness, prevention of antimicrobial resistance. |
| Quality Assurance/Improvement Department | Monitoring medication safety and identifying areas for improvement. | Collecting and analyzing data on medication errors, adverse drug events, and medication-related incidents. | Systemic improvements in medication safety practices, reduced frequency of errors, enhanced patient safety culture. |
| Ministry of Health (and related regulatory bodies) | Setting national drug policies, standards, and guidelines; drug procurement and regulation. | Developing and enforcing national drug formularies, guidelines for rational drug use, monitoring drug quality and pricing. | Ensuring access to essential medicines, promoting cost-effectiveness in drug expenditure, standardized medication practices across the country. |
| Training and Education Departments (within healthcare institutions) | Providing ongoing education and training to healthcare professionals. | Developing and delivering training modules on dose management principles, pharmacoeconomics, and drug safety. | Enhanced knowledge and skills of healthcare providers, leading to better medication management practices. |
Target Customers and Departments for Dose Management Programs in Mauritania
- Hospitals (Public and Private): Facilities with inpatient and outpatient services are prime beneficiaries. This includes large general hospitals, specialized clinics, and smaller health centers.
- Pharmacies (Hospital and Community): Both hospital pharmacies responsible for dispensing within the facility and community pharmacies serving the wider population play a vital role.
- Government Health Agencies: Ministries of Health and related regulatory bodies that oversee healthcare policy, drug procurement, and quality assurance.
- Healthcare Professionals: Doctors, nurses, pharmacists, and other allied health professionals involved in patient care and medication management.
- Patients: While not directly managing the program, patients are the ultimate beneficiaries, experiencing improved health outcomes and reduced adverse drug events.
- Pharmaceutical Companies and Distributors: While not directly operating the program, their collaboration is essential for ensuring availability of quality medications and providing relevant drug information.
- Non-Governmental Organizations (NGOs) and International Aid Organizations: Organizations working on health initiatives in Mauritania can be key partners in implementing and supporting dose management programs, especially in underserved areas.
Dose Management Program Process In Mauritania
The Dose Management Program in Mauritania aims to ensure the appropriate, safe, and effective use of medication. This workflow outlines the process from an initial inquiry to the full execution of the program's interventions. The program relies on a multi-faceted approach involving data collection, analysis, stakeholder engagement, and targeted interventions.
| Stage | Description | Key Activities | Responsible Parties | Key Outputs |
|---|---|---|---|---|
| The process begins when a need for dose management is identified, either through a formal request or observed trends. | Receiving and documenting inquiries, reviewing existing health data for potential issues, identifying specific areas of concern (e.g., drug resistance, high cost of specific medications). | Ministry of Health (MoH) officials, Public Health Agencies, Healthcare Facilities, International Partners. | Documented inquiries, initial problem statements, identified areas for investigation. |
| Gathering comprehensive data to understand current medication use patterns and identify specific dose-related challenges. | Collecting data on prescription patterns, medication dispensing records, drug utilization studies, adverse drug reaction reports, patient outcomes, cost of medications, and supply chain information. | Healthcare facilities (hospitals, clinics), pharmacies, national drug regulatory agencies, research institutions. | Comprehensive dataset on medication use, baseline performance indicators, identified high-risk medications or patient populations. |
| Analyzing the collected data to pinpoint specific problems related to dose management. | Statistical analysis of prescription data, identifying deviations from standard treatment guidelines, analyzing trends in drug resistance, evaluating cost-effectiveness of different dosing regimens, identifying common errors in prescribing or dispensing. | Pharmacists, epidemiologists, data analysts, clinical pharmacologists. | Identified dose-related problems (e.g., under-dosing, over-dosing, inappropriate duration), prioritized areas for intervention, evidence-based rationale for interventions. |
| Developing targeted strategies and interventions to address the identified dose management issues. | Developing or adapting Standard Treatment Guidelines (STGs) and essential drug lists, designing educational materials for prescribers and dispensers, planning for drug audits and feedback mechanisms, exploring technological solutions (e.g., e-prescribing where feasible), developing patient education strategies. | Clinical pharmacologists, pharmacists, physicians, MoH committees, public health experts. | Documented intervention plans, revised STGs/protocols, training curricula, communication strategies, resource allocation plans. |
| Involving relevant stakeholders and equipping them with the knowledge and skills to implement the planned interventions. | Conducting workshops and training sessions for healthcare professionals (doctors, nurses, pharmacists), engaging with hospital administrators and policymakers, disseminating information through various channels, establishing communication networks. | MoH, training institutions, healthcare facility management, professional associations. | Trained healthcare professionals, established communication channels, increased awareness and buy-in from stakeholders. |
| Putting the designed interventions into practice within healthcare facilities and the broader health system. | Rollout of revised protocols and guidelines, implementation of prescription audits, distribution of educational materials, introduction of new dispensing practices, active monitoring of drug use. | Healthcare facilities (doctors, nurses, pharmacists), pharmacy departments, MoH drug quality control units. | Adherence to new protocols, improved prescription quality, reduced medication errors, documented changes in practice. |
| Continuously tracking the impact of the interventions and assessing their effectiveness. | Regular data collection on key performance indicators (e.g., adherence to guidelines, reduction in adverse events, cost savings), conducting periodic audits, gathering feedback from healthcare professionals and patients, assessing changes in patient outcomes. | MoH, public health agencies, monitoring and evaluation teams, research institutions. | Performance reports, evaluation findings, identification of successes and challenges, data for further decision-making. |
| Using the findings from monitoring and evaluation to refine and improve the dose management program. | Disseminating evaluation results to stakeholders, holding review meetings, making necessary adjustments to interventions, updating guidelines, identifying new areas for focus, incorporating lessons learned into future planning. | MoH, program steering committee, all stakeholders. | Revised intervention strategies, updated program guidelines, enhanced program effectiveness, sustained improvement in dose management. |
Dose Management Program Workflow in Mauritania
- Inquiry and Identification of Need
- Data Collection and Baseline Assessment
- Data Analysis and Identification of Issues
- Intervention Design and Planning
- Stakeholder Engagement and Training
- Implementation of Interventions
- Monitoring and Evaluation
- Feedback and Continuous Improvement
Dose Management Program Cost In Mauritania
Dose management programs are crucial for ensuring optimal medication efficacy and minimizing adverse drug reactions. In Mauritania, the cost of such programs is influenced by a variety of factors, including the specific services offered, the type of medications being managed, and the healthcare provider. Generally, these costs are borne by patients, insurance providers, or government subsidies, depending on the prevailing healthcare system structure. Pricing can fluctuate significantly, making it essential to understand the underlying cost drivers to estimate potential expenditures. The local currency, the Mauritanian Ouguiya (MRU), is the primary unit of cost. While precise, universally standardized pricing is rare, a general overview of contributing factors and approximate cost ranges can be provided.
| Service Component | Estimated Cost Range (MRU) | Notes |
|---|---|---|
| Initial Medication Review & Assessment | 5,000 - 15,000 | Basic consultation with a pharmacist or physician to review current medications and patient history. |
| Ongoing Patient Monitoring (Per Month) | 3,000 - 10,000 | Includes regular check-ins, adherence monitoring, and minor dosage adjustments. May be lower for less complex cases. |
| Therapeutic Drug Monitoring (Per Test) | 8,000 - 25,000 | Cost of laboratory analysis for specific drug levels. Varies by drug and laboratory. |
| Pharmacogenomic Testing (One-time) | 30,000 - 80,000+ | Genetic testing to predict drug response. Primarily for complex or high-risk medication management. |
| Medication Management Software/Platform Subscription (Annual) | 20,000 - 60,000+ | If the program utilizes specific software for tracking and patient engagement. More common in private facilities. |
| Comprehensive Dose Management Program (Annual Estimate) | 50,000 - 200,000+ | This is a broad estimate for a program involving regular monitoring, multiple consultations, and potentially some diagnostic tests. Excludes high-end pharmacogenomics unless specified. |
Key Pricing Factors for Dose Management Programs in Mauritania
- Type of Service: Basic medication review, complex pharmacogenomic testing, or ongoing patient monitoring will have vastly different cost structures.
- Medication Complexity: Managing a single chronic condition medication will be less expensive than managing multiple medications for co-morbidities or high-risk drugs.
- Provider Type: Costs can vary between public hospitals, private clinics, and specialized pharmacy services.
- Technology Integration: Programs utilizing advanced software for tracking, reminders, or data analysis may incur higher upfront or subscription fees.
- Frequency of Consultations: The number of patient-pharmacist or patient-physician interactions required for effective dose management will directly impact costs.
- Diagnostic Testing: If blood tests or other diagnostic procedures are needed to optimize dosing (e.g., therapeutic drug monitoring), these add to the overall expense.
- Geographic Location: While less of a factor for the program itself, accessibility and potential travel costs for patients in remote areas can be an indirect consideration.
- Insurance Coverage and Subsidies: The extent to which national health insurance or government programs cover dose management services will significantly alter out-of-pocket expenses for patients.
Affordable Dose Management Program Options
Managing medication doses effectively is crucial for patient outcomes and controlling healthcare costs. An Affordable Dose Management Program aims to achieve this through various strategies, including the implementation of value bundles and the adoption of cost-saving measures. Value bundles, in this context, often refer to a package of services and medications designed to treat a specific condition or a group of related conditions. By coordinating care and standardizing treatment protocols within these bundles, providers can often achieve better outcomes at a more predictable cost. Cost-saving strategies encompass a wide range of approaches, from negotiating better prices for medications to utilizing evidence-based treatment protocols that avoid unnecessary or high-cost interventions.
| Strategy Type | Description | Potential Cost Savings |
|---|---|---|
| Value Bundles | A pre-defined set of services and medications for a specific condition (e.g., diabetes management, heart failure treatment). Often includes physician visits, lab tests, physical therapy, and necessary medications. | Reduced administrative costs, improved care coordination, prevention of complications, optimized medication regimens. |
| Generic & Biosimilar Substitution | Encouraging or mandating the use of lower-cost generic and biosimilar alternatives when clinically appropriate. | Significant reduction in drug acquisition costs. |
| Formulary Management | Developing and maintaining a list of preferred medications that are cost-effective and clinically proven. | Negotiating lower prices with manufacturers through preferred status, reduced spending on non-formulary drugs. |
| Medication Therapy Management (MTM) | Services provided by pharmacists to optimize drug therapy and improve therapeutic outcomes for patients with chronic conditions. | Reduced hospitalizations and emergency room visits due to medication-related problems, improved adherence, identification of drug interactions. |
| Price Negotiation | Leveraging purchasing power to negotiate discounts and rebates with pharmaceutical manufacturers and distributors. | Direct reduction in the cost of medications. |
| Evidence-Based Protocols | Utilizing treatment guidelines and protocols that are proven to be effective and cost-efficient, avoiding unnecessary or experimental treatments. | Prevention of ineffective or high-cost treatments, improved patient outcomes leading to fewer downstream costs. |
Key Components of Affordable Dose Management Programs
- Value-based purchasing and bundled payments for specific conditions.
- Formulary management and preferred drug lists.
- Generic and biosimilar utilization promotion.
- Patient education and adherence support.
- Pharmacist-led medication therapy management (MTM).
- Data analytics for identifying cost-saving opportunities and improving outcomes.
- Home delivery and mail-order pharmacy options.
- Telehealth and remote monitoring for chronic disease management.
Verified Providers In Mauritania
In Mauritania, ensuring you are accessing healthcare services from verified providers is paramount for your well-being. Franance Health stands out as a leader in this regard, offering a robust system of credentialing that guarantees a high standard of care. This commitment to verification not only builds trust but also ensures that patients receive safe, effective, and ethical medical treatment. When seeking healthcare in Mauritania, understanding the significance of these credentials and why Franance Health represents the best choice is crucial for informed decision-making.
| Feature | Franance Health Advantage | Patient Benefit |
|---|---|---|
| Credential Verification | Comprehensive background checks, license validation, and proof of qualifications. | Peace of mind knowing your provider is legitimate and competent. |
| Quality Assurance | Regular audits and inspections of facilities and services. | Access to a safe and well-equipped healthcare environment. |
| Specialist Expertise | Ensuring providers possess the necessary certifications and experience for their specialties. | Receiving specialized care from qualified medical professionals. |
| Ethical Standards | Upholding strict ethical guidelines and patient rights protocols. | Trustworthy care with respect for your privacy and autonomy. |
| Accessibility | Facilitating access to a network of verified and reputable healthcare providers. | Easier and more reliable access to the medical care you need. |
Key Aspects of Franance Health Credentials
- Rigorous vetting of medical professionals and facilities.
- Adherence to national and international healthcare standards.
- Continuous monitoring of provider performance and patient feedback.
- Focus on ethical practices and patient safety.
- Ensuring access to qualified and competent healthcare providers.
Scope Of Work For Dose Management Program
This document outlines the Scope of Work (SOW) for the implementation and ongoing management of a Dose Management Program. The objective is to ensure patient safety by optimizing radiation doses in medical imaging procedures, adhering to ALARA (As Low As Reasonably Achievable) principles while maintaining diagnostic image quality. This SOW details the technical deliverables and standard specifications required for a successful program.
| Deliverable | Description | Standard Specifications/Requirements | Acceptance Criteria |
|---|---|---|---|
| Dose Monitoring and Reporting System | Software solution to collect, store, and analyze radiation dose data from imaging modalities. | System compatibility with existing imaging equipment (CT, X-ray, Nuclear Medicine). Secure data storage. Ability to track patient dose by procedure, modality, and radiologist. Real-time or near real-time data acquisition. Compliance with DICOM Dose standards. | Successful data capture and reporting for 95% of eligible procedures. System uptime of 99.5%. User-friendly interface for data retrieval and analysis. |
| Dose Audit and Analysis Tools | Features within the dose monitoring system for conducting regular audits and trend analysis. | Capability to identify outliers and deviations from established protocols. Statistical analysis functions for dose trends. Benchmarking capabilities against national or institutional averages (if available). Tools for generating reports on dose variation. | Ability to generate reports identifying the top 10% of procedures with highest dose variance from protocol. Statistical significance confirmed for identified trends. |
| Image Quality Assessment Protocols | Defined procedures for evaluating diagnostic image quality in relation to radiation dose. | Development of objective and subjective image quality metrics. Protocols for blinded image reviews by qualified personnel. Correlation of image quality metrics with radiation dose parameters. | Documented protocols reviewed and approved by radiology and medical physics departments. Pilot study demonstrating correlation between dose reduction and acceptable image quality for at least three common procedures. |
| Standardized Dose Protocols and Guidelines | Development and implementation of standardized radiation dose protocols for common imaging procedures. | Protocols based on evidence-based practice and national/international guidelines (e.g., AAPM, IAEA, ACR). Inclusion of default parameters and optimization recommendations for different patient demographics (e.g., pediatric, adult). Clear documentation for each protocol. | Development of at least 20 standardized protocols covering the most frequently performed procedures. Protocols reviewed and approved by the Radiation Safety Committee and relevant clinical departments. Successful integration of protocols into modality worklists or PACS/RIS. |
| Training Materials and Curriculum | Comprehensive training program for radiology technologists, radiologists, and other relevant staff. | Modules covering ALARA principles, dose management system usage, protocol adherence, image quality assessment, and reporting procedures. Training delivered through a combination of online modules, in-person sessions, and hands-on practice. Competency assessments. | Development of training modules for all identified user groups. At least 90% of targeted staff complete the training. Successful completion of competency assessments by 95% of trainees. |
| Integration with PACS/RIS/HIS Systems | Seamless integration of the dose management system with existing Picture Archiving and Communication System (PACS), Radiology Information System (RIS), and Hospital Information System (HIS). | Bi-directional data flow to capture dose information and provide feedback. Integration to allow for patient demographic data import and report export. Adherence to HL7 and DICOM standards for interoperability. | Successful transfer of dose data from modalities to the dose management system, linked to the correct patient and procedure. Ability to access dose reports from within PACS/RIS. Verification of data integrity post-integration. |
| Regular Performance Reports and Recommendations | Periodic reports detailing the program's performance and actionable recommendations for continuous improvement. | Reports to include overall dose trends, protocol adherence rates, outlier analysis, impact of interventions, and identified areas for further optimization. Recommendations for protocol updates, training enhancements, or equipment calibration. Reports delivered quarterly. | Delivery of comprehensive quarterly reports. Recommendations clearly articulated with supporting data. Evidence of implementation of at least one recommended action per quarter based on report findings. |
Key Technical Deliverables
- Dose Monitoring and Reporting System Implementation
- Dose Audit and Analysis Tools
- Image Quality Assessment Protocols
- Standardized Dose Protocols and Guidelines
- Training Materials and Curriculum Development
- Integration with PACS/RIS/HIS Systems
- Regular Performance Reports and Recommendations
Service Level Agreement For Dose Management Program
This Service Level Agreement (SLA) outlines the performance standards and commitments for the Dose Management Program. It defines the response times for issue resolution and the uptime guarantees for the program's core services.
| Service Level | Definition | Target Response Time (Business Hours) | Uptime Guarantee |
|---|---|---|---|
| Critical Incident | An issue that renders the Dose Management Program completely unavailable or significantly impairs its core functionality, preventing patient care decisions. | 1 hour | 99.9% per month |
| High Priority Incident | An issue that significantly degrades the performance of the Dose Management Program but does not render it completely unavailable. This may include slow performance or intermittent errors affecting a subset of users or functionalities. | 4 business hours | 99.5% per month |
| Medium Priority Incident | An issue that affects non-critical functionality or causes minor inconveniences. The Dose Management Program remains largely functional. | 8 business hours | 99.0% per month |
| Low Priority Incident | A general question, enhancement request, or minor bug that does not impact program functionality. | 2 business days | N/A (Focus on resolution time) |
Key Performance Indicators (KPIs)
- Response Time: The maximum allowed time from when a critical incident is reported to when the Dose Management Program support team begins active resolution.
- Uptime: The percentage of time the Dose Management Program is operational and accessible to authorized users.
In-Depth Guidance
Frequently Asked Questions
Phase 02: Execution
Ready when you are
Let's scope your Dose Management Program in Mauritania project in Mauritania.
OEM Approved
54Regions
Scaling healthcare logistics and technical systems across the entire continent.